Nachrichten zur Hims & Hers Health Inc. Aktie

Hims & Hers: Strong Q1 Masks Problematic Long-Term Value Proposition (NYSE:HIMS)

Hims & Hers Health, Inc.s Q1 results show 111% growth, yet shares fell 8%. Click for a look at the…

Hims & Hers (HIMS) Plunges as Weak Outlook Tempers 300% Profit Jump

Profit Soars, But Outlook Stumbles, Hims & Hers Drops Hard…

Hims & Hers stock jumps after blowout quarter, long-term guidance stuns Street

Shares of Hims & Hers Health (HIMS) surged 10% on Tuesday morning after the telehealth company posted first-quarter results that…

Looking At Hims & Hers Healths Recent Unusual Options Activity

Whales with a lot of money to spend have taken a noticeably bullish stance on Hims & Hers Health. Looking…

Hims & Hers Stock Jumps as Q1 Sales More Than Double

Hims & Hers Health beat first-quarter profit and revenue forecasts as sales more than doubled.…

Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped

Investors are buying Hims & Hers Health (NYSE: HIMS) stock hand over fist after the mail-order drugs company reported an…

Hims & Hers Health: Strong Financial Performance and Strategic Initiatives Drive Buy Rating

Hims & Hers Health (HIMS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday.…

Needham maintains Buy rating on Hims & Hers with $61 price target By Investing.com

Needham maintains Buy rating on Hims & Hers with $61 price target…

Hims & Hers Health: Hold Rating Amid Market Challenges and Competitive Pressures

TD Cowen analyst Jonna Kim has maintained their neutral stance on HIMS stock, giving a Hold rating today. Jonna Kim…

Buy Rating on Hims & Hers Health: Growth Potential in Weight Loss Segment and Future Revenue Targets

Ryan MacDonald, an analyst from Needham, reiterated the Buy rating on Hims & Hers Health (HIMS – Research Report). The…

Whats Next For HIMS Stock After An Upbeat Q1?

Hims & Hers Health (NYSE: HIMS), a telehealth platform, recently released its Q1 financial results, revealing significant year-over-year growth. The…

Leerink maintains Hims & Hers stock at $40 price target By Investing.com

Leerink maintains Hims & Hers stock at $40 price target…

Morgan Stanley maintains Hims & Hers stock with $40 target By Investing.com

Morgan Stanley maintains Hims & Hers stock with $40 target…

Hims & Hers Health: Balancing Impressive Growth with Emerging Challenges – A Hold Recommendation

Craig Hettenbach, an analyst from Morgan Stanley, reiterated the Hold rating on Hims & Hers Health (HIMS – Research Report).…

Sell Rating for Hims & Hers Health Amid Growth Challenges and Market Uncertainties

Analyst Daniel Grosslight from Citi maintained a Sell rating on Hims & Hers Health (HIMS – Research Report) and increased…

Hims & Hers mit starkem 1. Quartal und Wachstumszielen für 2030 – nach Novo Nordisk sollen weitere Partnerschaften folgen

Hims & Hers kann den Umsatz mehr als verdoppeln und die Abonnentenanzahl um 38 % auf 2,4 Mio. steigern.…

Hims & Hers Stock Slides Pre-Market As Q2 Sales View Misses Estimates, But Retail Traders Shrug It Off

Telehealth firm Hims & Hers Health Inc. (HIMS) reported strong first-quarter 2025 results, with revenue more than doubling year-over-year to…

Hims & Hers Health Inc (HIMS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ...

Hims & Hers Health Inc (HIMS) reports a 111% revenue surge and outlines future growth strategies amid expanding service offerings…

Hims & Hers Stock (HIMS) Falls as Cautious Outlook Dims Massive Revenue Growth

The stock of Hims Hers Health Inc. ($HIMS) fell more than 4% in after-hours trading after the telehealth company…

US telehealth company Hims & Hers posts strong Q1 revenue

Hims & Hers reported US$586 million in first-quarter revenue, surpassing analysts’ expectations of US$538 million.…

Hims & Hers Health Reports Strong Q1 2025 Growth

Hims & Hers Health, Inc. ( ($HIMS) ) has released its Q1 earnings. Here is a breakdown of the information…

HIMS Stock Dips Pre-Market Despite Q1 Earnings Beat, Gross Margin Down

Hims & Hers first-quarter 2025 performance reflects continued strength in its online revenue channel on the back of solid product…

Hims & Hers struggles post market despite strong Q1 results and 2025 outlook

Although Hims & Hers Health (NYSE:HIMS) handily beat Street expectations on both lines in its Q1 financial results and also…

Hims & Hers Slips 5% on Weak Q2 Guidance Despite Strong Q1 Beat

Hims & Hers Health (HIMS) stock fell nearly 5% to $39.88 in after-hours trading despite Q1 earnings of $0.20 per…

Heres What Key Metrics Tell Us About Hims & Hers Health (HIMS) Q1 Earnings

While the top- and bottom-line numbers for Hims & Hers Health (HIMS) give a sense of how the business performed…

Earnings call transcript: Hims & Hers Q1 2025 results show strong growth but miss EPS forecast By Investing.com

Earnings call transcript: Hims & Hers Q1 2025 results show strong growth but miss EPS forecast…

Hims & Hers (HIMS) Blows Out Earnings Expectations

Hims & Hers Health (NYSE:HIMS) reported a strong financial performance for Q1 2025, with revenue reaching $586 million, marking a…

Ford, Palantir, Hims earnings breakdowns: Market Domination Overtime

US stocks (^DJI, ^IXIC, ^GSPC) cap the trading day off in negative territory. Julie Hyman and Josh Lipton look back…

Hims & Hers Health, Inc. (HIMS) Beats Q1 Earnings and Revenue Estimates

Hims & Hers Health (HIMS) delivered earnings and revenue surprises of 66.67% and 8.91%, respectively, for the quarter ended March…

Hims & Hers Health, Inc. (HIMS) Beats Q1 Earnings and Revenue Estimates

Hims & Hers Health (HIMS) delivered earnings and revenue surprises of 66.67% and 8.91%, respectively, for the quarter ended March…

Hims & Hers gives weak outlook but says more collaborations are coming

Hims & Hers shares fell in extended trading on Monday after the company reported first-quarter earnings that offered soft guidance.…

Hims & Hers Health Q1 Earnings: Revenue Jumps 111%, Subscribers Up 38%, Q2 Guidance Falls Short Of Estimates, Shares Slide - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health reports first-quarter revenue of $586.01 million, beating estimates of $538.2 million, according to Benzinga.…

dpa-AFX ProFeed